Paclitaxel responses differed between human cancer cell lines. After 4 h exposure, 30 nM in Caov-3 ovarian cells and 100 nM in A-498 kidney cells reduced interphase microtubule dynamicity by 31% and 63%, respectively. In a separate 24 h proliferation assay, 30 nM completely inhibited Caov-3 live-cell accumulation, whereas 100 nM inhibited A-498 accumulation by 72.1%. Proliferation inhibition is distinct from the fraction of cells killed. [2]
Paclitaxel suppresses purified microtubule dynamics
Biochemical assay · Phosphocellulose-purified, MAP-free bovine brain tubulin (17 μM), assembled from axoneme seeds [1]
At 250 nM paclitaxel, shortening and overall dynamicity decreased relative to ethanol vehicle; growth rate and catastrophe frequency were not significantly changed. Taccalonolide AJ was a separate comparator, not a combination treatment.
Literature-Reported Treatment Conditions
- Treatment concentration
- 250 nM paclitaxel
- Exposure duration
- 30 min to steady state at 35°C; 10 min real-time recordings
- Method
- Single-agent exposure; see model-specific methods.
- Vehicle
- Ethanol vehicle
- Reported limits
- No Adooq lot tested; supplier material identity is as reported, without independent stereochemical or purity verification.
Methods and source locations
Compound reported in the paper: Paclitaxel (Taxol); Compound label in the paper: paclitaxel
Parent-compound research evidence; no supplier or lot equivalence claim.
Table 1 (vehicle and 250 nM PTX columns and footnotes); Results, purified-tubulin dynamics; Methods, Materials and Microtubule dynamic instability with phosphocellulose purified tubulin
Microtubule plus-end shortening rate: Differential interference contrast microscopy; approximately 25 microtubules per condition in table footnote; Student’s t-test. — Table 1, Shortening rate row
Overall microtubule dynamicity: Microtubule tracking; table gives no error estimate for dynamicity. — Table 1, Dynamicity row
Growth rate and catastrophe frequency: Vehicle versus 250 nM PTX; absence of statistical significance is not proof of equivalence. — Table 1, Growth rate and Catastrophe frequency rows; Results comparison paragraph
Microtubule dynamics in living ovarian and kidney cancer cells
Cell-based study · Caov-3 human ovarian adenocarcinoma and A-498 human kidney carcinoma cells [2]
Paclitaxel reduced growth and shortening rates and overall dynamicity in both cell lines at different extracellular concentrations. A-498 pause duration increased significantly; Caov-3 pause duration did not. These measurements concern peripheral interphase microtubules, not direct tracking of spindle microtubules.
Literature-Reported Treatment Conditions
- Treatment concentration
- Caov-3: 30 nM; A-498: 100 nM added to culture medium
- Exposure duration
- 4 h exposure; dynamics recorded for 0–2 h afterward in medium lacking taxol
- Method
- Single-agent exposure; see model-specific methods.
- Vehicle
- 10 mM stock in methanol, intermediate dilution in PIPES buffer; final methanol fraction not stated
- Reported limits
- No Adooq lot tested; supplier material identity is as reported, without independent stereochemical or purity verification.
Methods and source locations
Compound reported in the paper: Paclitaxel (Taxol); Compound label in the paper: taxol
Parent-compound research evidence; no supplier or lot equivalence claim.
Tables 1–3; Results, Microtubule Dynamics in Untreated Caov-3 Ovarian Tumor Cells and A-498 Kidney Tumor Cells through Taxol Reduced Dynamicity; Materials and Methods, Materials and dynamics analysis
Overall dynamicity: Quantitative fluorescence video microscopy after rhodamine-tubulin microinjection. Microtubules: Caov-3 36 control/34 treated; A-498 40 control/26 treated; counts are not independent experiments. — Table 3, Dynamicity and Number of microtubules rows
Microtubule growth rate: Student’s t-test as reported; control versus treated. — Table 2, Growth rate row and significance footnotes
Pause duration: Reported lack of significant change retained for Caov-3. — Table 3, Pause duration row and footnotes; Results, Taxol Increased the Duration and Percentage of Time in the Paused State
Paclitaxel inhibits proliferation with cell-line-dependent sensitivity
Cell-based study · Caov-3 ovarian adenocarcinoma and A-498 kidney carcinoma cells [2]
At 24 h, 30 nM taxol completely inhibited Caov-3 proliferation, whereas 100 nM inhibited A-498 proliferation by 72.1%. The endpoint is net live-cell accumulation relative to untreated parallel cultures, not a direct fraction of cells killed.
Literature-Reported Treatment Conditions
- Treatment concentration
- Concentration series; representative reported exposures: Caov-3 30 nM and A-498 100 nM
- Exposure duration
- 24 h
- Method
- Single-agent exposure; see model-specific methods.
- Vehicle
- Methanol stock with buffer intermediate dilution; final solvent fraction not stated
- Reported limits
- No Adooq lot tested; supplier material identity is as reported, without independent stereochemical or purity verification.
Methods and source locations
Compound reported in the paper: Paclitaxel (Taxol); Compound label in the paper: taxol
Parent-compound research evidence; no supplier or lot equivalence claim.
Figure 1 and caption; Results, Low Concentrations of Taxol Inhibit Proliferation; Methods, Cell Culture and Proliferation and Materials
Inhibition of live-cell accumulation: Hemocytometer live-cell counts at addition and 24 h, compared with parallel taxol-free culture. Figure values are means and SEs of 4 independent Caov-3 experiments and 11 independent A-498 experiments. Values >100% indicate net cell loss. — Results, Low Concentrations of Taxol Inhibit Proliferation; Figure 1 and caption